ClinicalTrials.gg
Drug

Lurasidone clinical trials

Also written Latuda and SM-13496.

studies test it
66
open now
4
in phase 3
35
first study started
2002

How each study uses lurasidone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the lurasidone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
28 Oct 2010 · LATUDA · NDA 200603 (FDA, Drugs@FDA)
European Union
21 Mar 2014 · Latuda · EMEA/H/C/002713 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Lurasidone
36
Lurasidone HCl
11
Lurasidone 40 mg
3
Lurasidone 80 mg
3
Lurasidone 20 mg
3

Brand

Latuda
21

Development codes

SM-13496
3
DSP-1349M
1

Studies by the year they started

66 studies that test it; most in 2008 (11)

Studies that test lurasidone, by start year
YearStudies
20022
20042
20072
200811
20094
20103
20116
20127
20136
20146
20151
20173
20183
20191
20201
20213
20221
20242
20262

By phase

A phase 1/2 study counts in both.

Phase 1
12
Phase 2
6
Phase 3
35
Phase 4
11
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 52 · Other 14

Sumitomo Pharma America, Inc. (37) · Sumitomo Pharma (Suzhou) Co., Ltd. (6) · Sumitomo Pharma Co., Ltd. (5) · Massachusetts General Hospital (2) · New York State Psychiatric Institute (2) · Bukwang Pharmaceutical (2) · Northwestern University (1) · Lakshmi N Yatham (1)

Often tested with

Tested in the same studies.

Escitalopram (2) · Quetiapine (2) · Cariprazine (1) · Aripiprazole (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Lurasidone is the comparator. A study of two new drugs counts under both.

Reaching primary completion within a year · 2, 1 in phase 3

Studies that test lurasidone, phase 3 first.

Studies

Open first, then newest update. How each study uses lurasidone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 66

See all 66 studies that test lurasidone →

Given beside what is tested · 2 — lurasidone is usual care or a partner of the new treatment
As the comparator · 3 — what is tested is compared with lurasidone

Codes

What other systems call lurasidone · ClinicalTrials.gg INT006563

  • MeSH (NLM) D000069056Lurasidone HydrochlorideConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 22IC88528TLURASIDONEConfirmed FDA, NLM, Wikidata
  • RxNorm 1040028Confirmed FDA, Wikidata
  • Wikidata Q416992lurasidoneConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C77575LurasidoneOne source FDA
  • DrugBank DB08815One source Wikidata

Also registered as lurasidone hydrochloride (UNII O0P4I5851I · RxNorm 1040027).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.